Inventor · disambiguated record
Ryan White
Also filed as: WHITE RYAN · WHITE RYAN D
36 granted patents·12 pending applications·289 citations·filing 2005–2025
97Inventor score
Top patents by PatentIndex Score
48 records- 0196US9611261B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Apr 4, 2017·25 cites·40 claims
- 0296US7700607B2Substituted pyridone compounds and methods of useHU ESSA·Filed 2007·Granted Apr 20, 2010·88 cites·4 claims
- 0395US9085576B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Jul 21, 2015·31 cites·60 claims
- 0494US11718617B2Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of useAMGEN INC·Filed 2022·Granted Aug 8, 2023·4 cites·30 claims
- 0594US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 0694US8426447B2Spiro-tricyclic ring compounds as beta-secretase modulators and methods of useWHITE RYAN·Filed 2009·Granted Apr 23, 2013·58 cites·22 claims
- 0793US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 0893US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 0988US8404694B2Aurora kinase modulators and method of useWHITE RYAN·Filed 2009·Granted Mar 26, 2013·7 cites·11 claims
- 1087US7776857B2Aurora kinase modulators and method of useAMGEN INC·Filed 2008·Granted Aug 17, 2010·10 cites·17 claims
- 1185US7893061B2Alkyne-substituted pyridone compounds and methods of useAMGEN INC·Filed 2007·Granted Feb 22, 2011·8 cites·15 claims
- 1282US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 1382US7981891B2Aurora kinase modulators and method of useAMGEN INC·Filed 2010·Granted Jul 19, 2011·7 cites·12 claims
- 1481US12319691B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 1581US8957083B2Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of useMINATTI ANA ELENA·Filed 2011·Granted Feb 17, 2015·4 cites·19 claims
- 1680US9556135B2Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Granted Jan 31, 2017·2 cites·38 claims
- 1780US9012446B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Apr 21, 2015·4 cites·20 claims
- 1880US8063055B2Substituted pyridone compounds and methods of useHU ESSA·Filed 2010·Granted Nov 22, 2011·3 cites·9 claims
- 1979US11332459B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2018·Granted May 17, 2022·2 cites·16 claims
- 2078US8497264B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useCHEN JIAN J·Filed 2011·Granted Jul 30, 2013·4 cites·29 claims
- 2176US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 2275US9096615B2Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereofAMGEN INC·Filed 2014·Granted Aug 4, 2015·2 cites·32 claims
- 2375US8962859B2Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of useEPSTEIN OLEG·Filed 2012·Granted Feb 24, 2015·5 cites·12 claims
- 2474US2025388574A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 2573US9346827B25-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of useDINEEN THOMAS·Filed 2012·Granted May 24, 2016·2 cites·14 claims
- 2673US9296759B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2012·Granted Mar 29, 2016·2 cites·11 claims
- 2772US9365522B2Pyrazole amide derivativeAMGEN INC·Filed 2015·Granted Jun 14, 2016·2 cites·14 claims
- 2871US12252489B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 2971US9725469B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Aug 8, 2017·1 cites·15 claims
- 3070US9777019B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2016·Granted Oct 3, 2017·1 cites·13 claims
- 3169US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 3269US8557816B2Aurora kinase modulators and method of useGEUNS-MEYER STEPHANIE·Filed 2011·Granted Oct 15, 2013·2 cites·9 claims
- 3359US2023113866A1Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 3458US7795254B2Benzomorpholine derivatives and methods of useAMGEN INC·Filed 2008·Granted Sep 14, 2010·0 cites·20 claims
- 3558US2014107109A1Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 3654US2023364070A1Pyrrolo[3,2-c]pyridin-4-one derivatives useful in the treatment of cancerSCORPION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3753US2024101576A1Heterocyclic inhibitors of egfr and/or her2, for use in the treatment of cancerSCORPION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3850US11572374B2N-cyano-7-azanorbornane derivatives and uses thereofAMGEN INC·Filed 2019·Granted Feb 7, 2023·0 cites·6 claims
- 3950US2013165445A1Aurora Kinase Modulators and Method of UseAMGEN INC·Filed 2013·Application pending·0 cites
- 4049US2023167073A1Aryl or heteroaryl derivativeTEIJIN PHARMA LTD·Filed 2021·Application pending·0 cites
- 4147US2015252011A1Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Application pending·0 cites
- 4246US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 4344US2014336182A1Aurora Kinase Modulators and Method of UseAMGEN INC·Filed 2013·Application pending·0 cites
- 4443US9309263B2Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereofAMGEN INC·Filed 2014·Granted Apr 12, 2016·0 cites·31 claims
- 4543US7763624B2Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitorsAMGEN INC·Filed 2006·Granted Jul 27, 2010·0 cites·34 claims
- 4642US7674907B2Furanopyridine derivatives and methods of useAMGEN INC·Filed 2005·Granted Mar 9, 2010·0 cites·13 claims
- 4742US2007054916A1Aryl nitrogen-containing bicyclic compounds and methods of useAMGEN INC·Filed 2005·Application pending·0 cites
- 4842US2015252059A1Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereofAMGEN INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryan White files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →